Total Payments
$889.21
2024 Payments
$28.87
Companies
9
Transactions
69
Medicare Patients
5,355
Medicare Billing
$424,771
Payment Breakdown by Category
Food & Beverage$846.43 (95.2%)
Education$42.78 (4.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $846.43 | 68 | 95.2% |
| Education | $42.78 | 1 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $380.40 | 39 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $123.42 | 6 | $0 (2020) |
| Lilly USA, LLC | $95.85 | 6 | $0 (2019) |
| ABBVIE INC. | $95.35 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $64.99 | 4 | $0 (2023) |
| Celgene Corporation | $62.47 | 4 | $0 (2019) |
| Allergan Inc. | $25.87 | 2 | $0 (2017) |
| DERMIRA, INC. | $22.74 | 1 | $0 (2019) |
| GENZYME CORPORATION | $18.12 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.87 | 2 | ABBVIE INC. ($28.87) |
| 2023 | $49.48 | 3 | Janssen Biotech, Inc. ($30.45) |
| 2022 | $51.12 | 2 | Janssen Biotech, Inc. ($51.12) |
| 2021 | $16.36 | 1 | NOVARTIS PHARMACEUTICALS CORPORATION ($16.36) |
| 2020 | $68.67 | 2 | Regeneron Healthcare Solutions, Inc. ($42.78) |
| 2019 | $153.82 | 8 | AbbVie, Inc. ($40.90) |
| 2018 | $50.76 | 3 | Regeneron Healthcare Solutions, Inc. ($32.64) |
| 2017 | $470.13 | 48 | Janssen Biotech, Inc. ($272.94) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: IMMUNOLOGY | ||||||
| 02/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Immunology | ||||||
| 09/07/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Immunology | ||||||
| 04/11/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Dermatology | ||||||
| 06/09/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Immunology | ||||||
| 05/26/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Immunology | ||||||
| 10/14/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $42.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/27/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Immunology | ||||||
| 11/12/2019 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Immunology | ||||||
| 09/17/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Dermatology | ||||||
| 08/20/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/20/2019 | DERMIRA, INC. | — | Food and Beverage | In-kind items and services | $22.74 | General |
| 06/11/2019 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Immunology | ||||||
| 05/22/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Dermatology | ||||||
| 05/15/2019 | AbbVie, Inc. | Skyrizi (Biological) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Immunology | ||||||
| 02/19/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Immunology | ||||||
| 10/17/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/08/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/11/2018 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/21/2017 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Immunology | ||||||
| 12/21/2017 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: Immunology | ||||||
| 12/06/2017 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Immunology | ||||||
| 12/06/2017 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,755 | 2,959 | $663,185 | $152,408 |
| 2022 | 13 | 1,421 | 2,546 | $397,070 | $112,762 |
| 2021 | 12 | 1,073 | 1,928 | $235,675 | $85,950 |
| 2020 | 11 | 1,106 | 2,003 | $235,355 | $73,652 |
Total Patients
5,355
Total Services
9,436
Medicare Billing
$424,771
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 510 | 916 | $241,412 | $60,813 | 25.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 268 | 268 | $119,854 | $22,265 | 18.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 275 | 458 | $92,168 | $21,824 | 23.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 102 | 132 | $41,844 | $11,403 | 27.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 136 | 148 | $49,736 | $10,883 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 113 | $25,534 | $8,975 | 35.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 27 | $15,645 | $3,595 | 23.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 183 | 724 | $31,712 | $3,577 | 11.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 63 | 68 | $13,616 | $2,657 | 19.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 27 | 27 | $10,737 | $2,497 | 23.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 40 | 40 | $11,313 | $1,810 | 16.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 12 | 14 | $5,726 | $1,145 | 20.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 22 | 24 | $3,888 | $963.11 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 300 | 479 | $86,923 | $30,578 | 35.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 211 | 362 | $55,637 | $16,689 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 119 | 141 | $31,623 | $11,497 | 36.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 194 | 283 | $33,412 | $11,300 | 33.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 122 | 122 | $45,922 | $10,203 | 22.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 109 | 122 | $36,072 | $9,291 | 25.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 66 | 80 | $21,720 | $6,902 | 31.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 77 | 77 | $20,658 | $4,406 | 21.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 142 | 786 | $35,125 | $3,733 | 10.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 32 | 33 | $12,144 | $2,983 | 24.6% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 11 | 13 | $5,984 | $2,039 | 34.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 14 | 15 | $6,361 | $1,749 | 27.5% |
About Dr. Ivan Rappaport, M.D
Dr. Ivan Rappaport, M.D is a Specialist healthcare provider based in Saratoga Springs, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881667905.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ivan Rappaport, M.D has received a total of $889.21 in payments from pharmaceutical and medical device companies, with $28.87 received in 2024. These payments were reported across 69 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($846.43).
As a Medicare-enrolled provider, Rappaport has provided services to 5,355 Medicare beneficiaries, totaling 9,436 services with total Medicare billing of $424,771. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Saratoga Springs, NY
- Active Since 02/09/2006
- Last Updated 09/21/2018
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881667905
Products in Payments
- STELARA (Biological) $171.33
- Tremfya (Drug) $101.61
- TALTZ (Drug) $95.85
- TREMFYA (Drug) $94.03
- DUPIXENT (Biological) $66.04
- Otezla (Drug) $62.47
- DUPIXENT DUPILUMAB INJECTION (Biological) $57.38
- Humira (Biological) $33.84
- COSENTYX (Biological) $30.42
- SKYRIZI (Biological) $28.87
- Skyrizi (Biological) $20.85
- COSENTYX (Drug) $19.03
- DUPIXENT (Drug) $18.12
- XOLAIR (Biological) $15.54
- RHOFADE (Drug) $13.92
- REMICADE (Biological) $13.43
- ACZONE (Drug) $11.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Saratoga Springs
Dr. David Kandath, Md, MD
Specialist — Payments: $27,606
Specialist $27,606
Dr. Faisal Chaudhary, M.d, M.D
Specialist — Payments: $22,770
Specialist $22,770
Dr. Stephen Dempsey, Md, MD
Specialist — Payments: $7,552
Specialist $7,552
Dr. Anthony Cutry, M.d.,Phd, M.D.,PHD
Specialist — Payments: $6,361
Specialist $6,361
Dr. Jeffrey Paul, M.d, M.D
Specialist — Payments: $5,626
Specialist $5,626
Dr. Gregory Pinto, M.d, M.D
Specialist — Payments: $4,271
Specialist $4,271